193
12
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9845 | Thrombin inhibitor 5 | ||
Thrombin inhibitor 5 (compound 385) 是一种凝血酶抑制剂,IC50范围为 0.1 μM~1 μM,可用于静脉血栓栓塞的研究。 | |||
T7674 |
Thrombin Receptor Activator for Peptide
|
Protease-activated Receptor | GPCR/G Protein |
Thrombin Receptor Activator for Peptide 也称为凝血因子 II 受体 (1-5) 或蛋白酶激活受体 1 (1-5),用于研究冠心病 (CHD)。 | |||
T19580 |
Thrombin (MW 37kDa)
凝血酶,Thrombin |
Thrombin | Proteases/Proteasome |
Thrombin (MW 37kDa) 是一种 Na+激活的胰蛋白酶样别构丝氨酸蛋白酶。它能够利用凝血酶识别序列对融合蛋白进行位点特异性切割,并可用于消化 GST 标记的蛋白。 | |||
T7625 |
TRAP-6
PAR-1 agonist peptide,Thrombin Receptor Activator Peptide 6,TRAP-6(2TFA) |
Protease-activated Receptor | GPCR/G Protein |
TRAP-6 (Thrombin Receptor Activator Peptide 6) 是一种多肽片段,是选择性的蛋白酶激活受体 1 (PAR1) 激动剂,通过凝血酶受体激活人血小板。 | |||
T7496 |
Thrombin Receptor Activator for Peptide 5 (TRAP-5)
Thrombin Receptor Activator for Peptide |
Protease-activated Receptor | GPCR/G Protein |
Thrombin Receptor Activator for Peptide 5 (TRAP-5) 也称为凝血因子 II 受体 (1-5) 或蛋白酶激活受体 1 (1-5),用于研究冠心病 (CHD)。 | |||
T17091 | Thrombin Inhibitor 2 | Others | Others |
Thrombin Inhibitor 2 is a small molecule direct thrombin inhibitor. Thrombin Inhibitor 2 has antithrombotic activity. | |||
T36553 |
Thrombin Receptor Peptide Ligand (trifluoroacetate salt)
|
||
Thrombin receptor peptide ligand is antagonist of the thrombin receptor (EC50s = 16-33 μM to inhibit platelet aggregation in vitro). It inhibits α-thrombin and platelet aggregation induced by thrombin receptor activating peptide in vitro when used at a concentration of 32 μM but does not affect platelet aggregation induced by ADP or collagen. It also inhibits thrombin- and TRAP-induced proliferation of vascular smooth muscle cells (VSMCs). Thrombin receptor peptide ligand (100 μmol/kg bolus, i.v... | |||
T10081 | Thrombin inhibitor 1 | Thrombin | Proteases/Proteasome |
Thrombin inhibitor 1 is a potent inhibitor of thrombin (Ki: 0.66 nM, 2xaPTT=0.43 μM). | |||
T36777 |
Thrombin Receptor Agonist Peptide (trifluoroacetate salt)
|
||
Thrombin receptor agonist peptide (TRAP-14) is a 14-amino acid peptide agonist of the α-thrombin receptor. It induces aggregation of washed platelets as well as platelets in citrated and hirudin plasma. TRAP-14 (100 μM) increases the cytosolic calcium concentration in isolated guinea pig pulmonary smooth muscle cells 5-fold over baseline. It increases pulmonary arterial pressure in isolated guinea pig lung when used at a concentration of 1 μM, which is comparable to the effect induced by 10 nM α... | |||
T72448 |
Thrombin inhibitor 6
|
||
Thrombin inhibitor6为高效的凝血酶抑制剂,IC50值为1 nM,表现出显著的抗凝作用。 | |||
TP2234 |
coagulation factor II (thrombin) B chain fragment [Homo sapiens]
|
Others | Others |
Thrombin is a "trypsin-like" serine protease that is encoded by the F2 gene in humans. Thrombin is produced by the enzymatic cleavage of two sites on prothrombin by activated Factor X (Xa). Thrombin in turn acts as a serine protease that converts soluble | |||
T80512 |
Thrombin receptor peptide ligand
|
Thrombin | Proteases/Proteasome |
Thrombin receptor peptide ligand为凝血酶受体的一种拮抗肽,用于抗血栓治疗。 | |||
T3757 |
NQ301
|
Thrombin; Platelet aggregation | Others; Proteases/Proteasome |
NQ301 是一种抗血栓剂,能够抑制胶原蛋白激发的兔血小板聚集,IC50=10 mg/mL。 | |||
T7137 |
I-191
|
Protease-activated Receptor | GPCR/G Protein |
I-191 是选择性有效的蛋白酶激活受体 2 拮抗剂。 | |||
T1986 |
Atopaxar
E5555,ER-172594-00 |
Protease-activated Receptor | GPCR/G Protein |
Atopaxar (E5555) 是一种高效、可口服的,选择性的,可逆的凝血酶受体蛋白酶激活受体-1 (PAR-1) 拮抗剂。它是一种抗血小板剂,能干扰血小板信号,可用于动脉粥样硬化血栓性疾病的研究。 | |||
T12870 |
SCH79797 dihydrochloride
|
Apoptosis; Others; Protease-activated Receptor | Apoptosis; GPCR/G Protein; Others |
SCH79797 dihydrochloride 是一种有效的特异性蛋白酶激活受体 1 (PAR1) 拮抗剂,IC50 为 70 nM,Ki 为 35 nM。SCH79797 dihydrochloride 具有抗增殖和促凋亡作用。 | |||
TQ0012 |
AZ3451
|
Protease-activated Receptor | GPCR/G Protein |
AZ3451 是蛋白酶激活受体 2 的变构拮抗剂,IC50值为 23 nM。 | |||
T6594 |
MNS
|
Syk; Src; p97 | Angiogenesis; Tyrosine Kinase/Adaptors; Ubiquitination |
MNS 是一种酪氨酸激酶抑制剂和广谱抗血小板药物,是一种 β-硝基苯乙烯衍生物。它完全抑制 U46619 (IC50:2.1 μM)、ADP (IC50:4.1 μM)、花生四烯酸 (IC50:5.8 μM)、胶原 (IC50:7.0 μM)和凝血酶 (IC50:12.7 μM)诱导的血小板聚集,并抑制 Src (IC50:27.3 μM)、Syk (IC50:2.8 μM) 和 FAK (IC50:97.6 μM)。 | |||
T2370 |
AC-55541
AOB2796 |
Proteasome; Protease-activated Receptor | GPCR/G Protein; Proteases/Proteasome; Ubiquitination |
AC-55541 (AOB2796) 是高选择性的蛋白酶激活受体 2(PAR2)激动剂,pEC50为6.7。它在 PI 水解测定和 Ca2+动态测定中的pEC50值为 5.9 和 6.6,在体内表现出伤害感受器活性。 | |||
TP1046 |
SLIGRL-NH2
Protease-Activated Receptor-2 Activating Peptide |
Protease-activated Receptor | GPCR/G Protein |
SLIGRL-NH2 (Protease-Activated Receptor-2 Activating Peptide) 为一种蛋白酶激活受体-2 (PAR-2) 激动剂,具有诱导非组胺能性瘙痒的功能。 | |||
T6295 |
Dabigatran
BIBR 953,BIBR 953ZW,达比加群 |
Thrombin | Proteases/Proteasome |
Dabigatran (BIBR 953ZW) 是一种口服抗凝剂,是一种可逆的,竞争性的直接凝血酶 (thrombin) 抑制剂,Ki=4.5 nM。它也抑制凝血酶诱导的血小板聚集 (IC50=10 nM)。 | |||
T22246 |
Argatroban Monohydrate
阿加曲班一水合物,阿加曲班 |
Thrombin | Proteases/Proteasome |
Argatroban Monohydrate 是一种 thrombin 选择性抑制剂。 | |||
T6370 |
AEBSF hydrochloride
AEBSF HCl,Pefabloc SC |
Thrombin; Serine Protease; Influenza Virus | Microbiology/Virology; Proteases/Proteasome |
AEBSF hydrochloride (Pefabloc SC) 是一种丝氨酸蛋白酶的不可逆抑制剂。 | |||
T5519 |
Bivalirudin
BG-8967,比伐卢定,Hirulog-1 |
Thrombin | Proteases/Proteasome |
Bivalirudin (BG-8967) 是一种直接凝血酶(thrombin)抑制剂,是一种肽类抗凝剂,可在侵入性心脏病,特别是在经皮冠状动脉介入中用于抗凝。 | |||
T7013 |
Vorapaxar
SCH 530348,MK-5348,沃拉帕沙 |
Protease-activated Receptor | GPCR/G Protein |
Vorapaxar (MK-5348) 是抗血小板药物,是一种选择性、口服活性和竞争性的凝血酶受体蛋白酶激活受体(PAR-1)拮抗剂,Ki 值为 8.1 nM。它靠剂量依赖性抑制凝血酶受体激活肽 (TRAP) 诱导的血小板聚集。 | |||
T0389 |
Dabigatran etexilate
达比加群酯,BIBR 1048 |
Thrombin | Proteases/Proteasome |
Dabigatran etexilate (BIBR 1048) 是一种 Dabigatran 前药,具有口服活性。它具有抗凝作用,能够预防心房颤动引起的静脉血栓栓塞和中风。 | |||
T1893 |
Parmodulin 2
ML 161 |
Protease-activated Receptor | GPCR/G Protein |
Parmodulin 2 (ML 161) 是一种蛋白酶激活受体 1(PAR1) 变构抑制剂,IC50为 0.26 μM。它是蛋白酶激活受体 1 (PAR1) 介导的血小板活化的抑制剂,可以抑制体外血小板聚集和体内血小板血栓形成。 | |||
T0155 |
Argatroban
MCI-9038,阿加曲班,MD-805,Argipidine |
Thrombin | Proteases/Proteasome |
Argatroban (MCI-9038) 是一种选择性的凝血酶抑制剂。 | |||
T22323 |
Enoxaparin sodium
|
Thrombin | Proteases/Proteasome |
Enoxaparin sodium 是一种低分子量肝素 (LMWH),已获得美国 FDA 批准,可用于医疗管理的 ST 段心肌梗死 (STEMI) 或 STEMI 及随后的经皮冠状动脉介入治疗 (PCI) 患者。它与抗凝血酶结合并增强其作用,并抑制凝血因子 XIa、IXa、Xa 和 IIa(凝血酶),从而防止血栓形成。 | |||
T5133 |
Dabigatran Etexilate Mesylate
甲磺酸达比加群酯,BIBR 1048MS,Dabigatran etexilate methanesulfonate |
Thrombin | Proteases/Proteasome |
Dabigatran Etexilate Mesylate (BIBR 1048MS) 是一种口服具有活性的 Dabigatran 前药,具有抗凝作用,能够预防心房颤动引起的静脉血栓栓塞和中风。 | |||
T8917 |
PAR-2-IN-1
IUN76750,8-(叔丁基)-6-氯咪唑并[1,2-B]吡啶-2-羧酸甲酯 |
Protease-activated Receptor | GPCR/G Protein |
PAR-2-IN-1 (IUN76750) 是一种 PAR-2 信号通路抑制剂,具有抗炎和抗癌作用。 | |||
T17265 |
Ximelagatran
EXANTA,H 376-95,H37695,希美加群,H 376/95,H-37695,H 37695 |
Thrombin | Proteases/Proteasome |
Ximelagatran (H 376-95) 是一种口服活性凝血酶抑制剂,可选择性的、竞争性的抑制游离和凝块结合的凝血酶。它是一种抗凝药物,具有快速起效的抗凝作用,可预测的,剂量依赖性的药代动力学和药效学。 | |||
T3098 |
Vorapaxar sulfate
SCH 530348 sulfate,Zontivity,vorapaxar monosulfate,沃拉帕沙 |
Protease-activated Receptor | GPCR/G Protein |
Vorapaxar sulfate (Zontivity) 是一种选择性、口服活性和竞争性的凝血酶受体蛋白酶激活受体(PAR-1)拮抗剂,Ki 值为 8.1 nM。它剂量依赖性抑制凝血酶受体激活肽 (TRAP) 诱导的血小板聚集,是抗血小板药物。 | |||
TP1065 |
PAR-4 Agonist Peptide, amide TFA
PAR-4-AP (TFA),AY-NH2 (TFA) |
Protease-activated Receptor | GPCR/G Protein |
PAR-4 Agonist Peptide, amide TFA (PAR-4-AP (TFA)) 是一种蛋白酶激活受体 4 (PAR-4) 激动剂,对 PAR-1 或 PAR-2 均无影响,其作用可被 PAR-4 拮抗剂阻断。 | |||
T7513 |
Protease-Activated Receptor-2, amide
蛋白酶活化的受体-2,酰胺,SLIGKV-NH2,H-丝氨酰亮氨酰异亮氨酰甘氨酰赖氨酰缬氨酰NH2 |
Protease-activated Receptor | GPCR/G Protein |
Protease-Activated Receptor-2, amide (SLIGKV-NH2) 是 PAR2 的激动剂,IC50为 10.4 M。 | |||
T1986L |
Atopaxar Hydrobromide
|
Protease-activated Receptor | GPCR/G Protein |
Atopaxar hydrobromide 是可口服的,高效选择性的可逆凝血酶受体蛋白酶激活受体-1 拮抗剂。它是一种抗血小板剂,能干扰血小板信号,用于动脉粥样硬化血栓性疾病的研究。 | |||
T10951 |
Dabigatran ethyl ester hydrochloride
N-[[2-[[[4-(氨基亚氨甲基)苯基]氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]-N-(2-吡啶基)-BETA-丙氨酸乙酯盐酸盐 |
Others; Thrombin | Others; Proteases/Proteasome |
Dabigatran ethyl ester hydrochloride 是一种核糖基二氢烟酰胺脱氢酶抑制剂,IC50=0.8 μM,也是一种凝血酶的抑制剂。 | |||
T2368 |
Edoxaban Tosylate Monohydrate
DU-176b,DU-176b tosylate Monohydrate,Lixiana,Edoxaban,依度沙班对甲苯磺酸盐一水化合物 |
Factor Xa; Thrombin | Metabolism; Proteases/Proteasome |
Edoxaban Tosylate Monohydrate (DU-176b tosylate Monohydrate) 是口服具有活力的 factor Xa 选择性抑制剂。它是一种抗凝剂,可用于预防中风,是一种凝血酶和凝血因子 IXaβ (FIXa) 的弱抑制剂,对 FXa 的选择性超过 10000 倍。它具有抗血栓形成的特性,可用于血栓栓塞性疾病的研究。 | |||
T4186 |
AC-264613
AC264613 |
Protease-activated Receptor | GPCR/G Protein |
AC-264613 是一种选择性蛋白酶激活受体 (PAR-2) 激动剂,pEC50为 7.5。 | |||
T40711 |
H-D-Phe-Pip-Arg-pNA dihydrochloride
S-2238 dihydrochloride,H-D-Phe-Pip-Arg-pNA dihydrochloride |
Others | Others |
H-D-Phe-Pip-Arg-pNA dihydrochloride (S-2238 dihydrochloride), a chromogenic substrate, mimics the N-terminal fragment of the A alpha chain of fibrinogen, the native substrate of thrombin. Specifically designed for thrombin detection, H-D-Phe-Pip-Arg-pNA dihydrochloride is employed for the quantification of antithrombin-heparin cofactor (AT-III). The AT-III assay utilizing this substrate is characterized by its sensitivity, accuracy, and ease of implementation. | |||
T7573 |
TFLLR-NH2
TFLLR-NH2(2TFA) |
Protease-activated Receptor | GPCR/G Protein |
TFLLR-NH2 是选择性的一种PAR1激动剂,EC50值为1.9 μM。 | |||
T7380 |
Protease-Activated Receptor-4
蛋白酶活化的受体-4 |
Protease-activated Receptor | GPCR/G Protein |
Protease-Activated Receptor-4 是蛋白酶激活受体 4 激动剂,具有抗血小板治疗。 | |||
T7623 |
PAR-4 Agonist Peptide, amide
AY-NH2,PAR-4 Agonist Peptide, amide(2TFA),PAR-4-AP |
Protease-activated Receptor | GPCR/G Protein |
PAR-4 Agonist Peptide, amide (AY-NH2) 是蛋白酶激活受体 4 (PAR-4) 的激动剂,对 PAR-1 或 PAR-2 均无影响,其作用可被 PAR-4 拮抗剂阻断。 | |||
T22676 |
Prothrombin (474-477) [Mus musculus]
|
Others | Others |
Prothrombin (coagulation factor II) is produced in the liver and is post-translationally modified in a vitamin K-dependent reaction that converts ten glutamic acids on prothrombin into gamma-carboxyglutamic acid. Prothrombin is proteolytically cleaved to | |||
T8362 |
Benzamidine hydrochloride
Benzamidine HCl,苄脒盐酸盐 |
Serine/threonin kinase; Serine Protease | Cell Cycle/Checkpoint; Metabolism; Proteases/Proteasome |
Benzamidine hydrochloride (Benzamidine HCl) 是可逆的胰蛋白酶样丝氨酸蛋白酶 (trypsin-like serine proteases) 竞争性抑制剂,对 uPA、类胰蛋白酶、胰蛋白酶和 Xa 因子作用的Ki 分别为 97 µM、20 µM、21 µM 和 110 µM。 | |||
T9892 |
JAMM protein inhibitor 2
Acetamide, 2-(2-ethylphenoxy)-N-[2-methyl-4-(1-pyrrolidinyl)phenyl]- |
Others | Others |
JAMM protein inhibitor 2 (Acetamide, 2-(2-ethylphenoxy)-N-[2-methyl-4-(1-pyrrolidinyl)phenyl]-) 是 JAMM 蛋白酶的抑制剂,可用于抗癌的研究。 对thrombin、Rpn11 和 MMP2 的 IC50 分别为 10 μM、46 μM 和 89 μM。 | |||
T25364L |
Efegatran sulfate
LY294468 sulfate,GYKI-14766 sulfate,LY 294468 sulfate,LY-294468 sulfate |
Thrombin | Proteases/Proteasome |
Efegatran sulfate (LY294468 sulfate) 是一种有效的凝血酶抑制剂,可用于治疗血栓类疾病。 | |||
T37034 |
H-Gly-Arg-pNA dihydrochloride
H-Gly-Arg-Pna 2HCl |
||
H-Gly-Arg-pNA dihydrochloride (H-Gly-Arg-Pna 2HCl) 属于多肽类,可与1,2凝血酶结合,可通过 405 纳米波长的比色检测进行定量,作为凝血酶活性的测量指标。 | |||
TP1143L |
Fibrinopeptide A, human acetate
Fibrinopeptide A, human acetate(25422-31-5 free base),Human fibrinopeptide A acetate |
Others | Others |
Fibrinopeptide A, human acetate (Human fibrinopeptide A acetate)(25422-31-5 free base) 是一种 16 个残基的短多肽,由凝血酶从纤维蛋白原上切割下来。纤维蛋白肽 A (FPA) 由纤维蛋白原蛋白的 N 末端 Aα 区域在被凝血酶切割后产生。 | |||
T36951 |
N-(p-Tosyl)-GPR-pNA acetate
|
Others | Others |
N-(p-Tosyl)-GPR-pNA acetate 是凝血酶的比色底物,可作为凝血酶活性的量度。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3839 |
Cycloolivil
Isoolivil,环橄榄树脂素 |
Free radical scavengers; Others; Platelet aggregation | Others; oxidation-reduction |
Cycloolivil (Isoolivil) 是一种天然多酚化合物,在橄榄树中具有显着的自由基清除活性。 Cycloolivil 具有抗氧化活性,它可以预防与血小板过度聚集相关的血栓并发症,是开发抗聚集治疗策略的基础。 | |||
T3781 |
Jujuboside B
酸枣仁皂苷 B,酸枣仁皂苷B |
Others | Others |
Jujuboside B 是一种提取自Zizyphus jujuba 中的活性成分,对血小板聚集具有抑制作用。 | |||
T3793 |
(20R)-Ginsenoside Rh1
20(R)-Ginsenoside Rh1,人参皂苷 R-RH1,人参皂苷R-RH1 |
Others | Others |
(20R)-Ginsenoside Rh1 (20(R)-Ginsenoside Rh1) 是 Ginsenoside Rh1 的 R 型异构体,分离自 Panax Ginseng 中,能够阻碍凝血酶诱导的纤维蛋白原向纤维蛋白的转化。 | |||
TN1054 |
Loureirin C
龙血素C,龙血素 C |
Others | Others |
Loureirin C 在体外能有效抑制凝血酶的活性。它具有抗菌,抗痉挛,抗炎,止痛,抗糖尿病和抗肿瘤作用。 | |||
T3S0601 |
Buddlejasaponin IVb
醉鱼草皂苷IVb,Saikosaponin 1b |
Others | Others |
Buddlejasaponin IVb (Saikosaponin 1b) 是一种三萜皂苷,从Clinopodium chinense (Benth.) O. Kuntze 中分离得到,能够缩短凝血时间,具有止血作用。 | |||
TN3831 |
(-)-Denudatin B
Denudatin B |
ATPase; Potassium Channel; Calcium Channel; PAFR | GPCR/G Protein; Membrane transporter/Ion channel; Metabolism |
(-)-Denudatin B (Denudatin B) 源自 Magnolia fargesii。 (-)-Denudatin B 通过抑制胶原蛋白和凝血酶诱导的磷酸肌醇分解,在高浓度下具有非特异性抗血小板作用。 | |||
T5S0896 |
Loureirin A
龙血素 A,龙血素A |
Akt; PI3K | Cytoskeletal Signaling; PI3K/Akt/mTOR signaling |
Loureirin A 是一种黄酮类物质,从龙血树中分离得到,能够降低Akt 的磷酸化,具有抗血小板聚集作用。 | |||
T5S2358 |
Dehydrocorydaline
Dehydrocorydalin,脱氢紫堇碱,13-Methylpalmatine |
BCL; PARP; p38 MAPK; Caspase; Parasite; Autophagy | Apoptosis; Autophagy; Chromatin/Epigenetic; DNA Damage/DNA Repair; MAPK; Microbiology/Virology; Proteases/Proteasome |
Dehydrocorydaline (13-Methylpalmatine) 是一种生物碱。它调节Bax,Bcl-2蛋白表达,激活caspase-7,caspase-8,并使PARP 失活。它能增强p38 MAPK 活化,具有抗炎、抗癌等功效。它具有强大的抗疟疾作用,并具低细胞毒性。 | |||
TN4917 | Rosenonolactone | Others | Others |
Rosenonolactone shows inhibitory activity against prolyl endopeptidase and thrombin. | |||
T36532 |
SCH 38519
|
||
SCH 38519 is an isochromanequinone fungal metabolite originally isolated from Thermomonospora. It inhibits aggregation induced by thrombin , as well as inhibits serotonin secretion in human platelets (IC50s = 68 and 61 μg/ml, respectively). It inhibits the growth of various Gram-negative and Gram-positive bacteria (mean MICs = 122.1 and 0.92 μg/ml, respectively). | |||
TN4860 |
Pueroside B
|
COX; PPAR | DNA Damage/DNA Repair; Immunology/Inflammation; Metabolism; Neuroscience |
Pueroside B may can treat coronary heart disease, it can interact with two or more targets[peroxisome proliferator activated receptor γ (PPAR-γ), angiotensin-converting enzyme (ACE), hydroxymethylglutaryl coenzyme A receptor (HMGR), cyclooxygenase-2 (COX2 | |||
TN6014 |
Norcepharadione B
鱼腥草 |
||
Norcepharadione B shows good inhibitory activity against the replication of HSV-1, it also shows antimalarial activity with EC50 values of 7.5mug/ml. Norcepharadione B exhibits significant cytotoxicity against five human tumor cell lines (A-549, SK-OV-3, |